Parkinson’s research clinic resumes appointments

Spring 2020 has been all about the Coronavirus pandemic. The strict requirements to prevent its spread have also applied to our work at the Parkinson’s Research Clinic. Thus, we had to temporarily suspend the on-site visits of our participants.

With the effective lockdown measures to limit the pandemic, the NCER-PD clinical team now can invite our participants of the Luxembourg Parkinson’s Study back to our facilities – both people with Parkinson’s disease and controls.

When it comes to visits at the Parkinson Research Clinic, participants can be assured that all recommended health and safety measures are applied. In order to achieve physical distancing, the team is inviting less patients than usual on a daily basis, in order to ensure the health and safety of both participants and staff, of course, all hygiene measures are strictly followed. In addition, the members of the clinical team are regularly tested for Covid-19 in order to further reduce any risk of viral spread.

Still, whenever you feel insecure or you consider yourself as vulnerable, the team is happy to offer telephone questionnaires that allow for remote participation.

“We are happy to finally resume the invitations of our participants to join the Parkinson’s Research Clinic and we would like to assure them that we are taking the utmost care in providing a safe environment to jointly advance research,” said Prof. Rejko Krüger, coordinator of the NCER-PD program .”The involvement of our participants is key to the success of our study. Continuing our annual follow-up visits will allow researchers to advance with our mission for better diagnosis and treatments.” 

Coronavirus - Information

As you heard from the news, the new Covid-19 virus currently is affecting many countries. Therefore, we compiled some advice on how you can take general precautions for yourself and the people around you. We have also created a dedicated “frequently asked questions” section to answer questions that people with Parkinson’s disease may have.

Parkinson’s research as key topic in the ‘RBS – Bulletin’

Parkinson’s research as key topic in the ‘RBS – Bulletin’

The Luxembourgish association, RBS – Center fir Altersfroen, has published in its latest magazine an article on the Luxembourg Parkinson Study. The article highlights how Luxembourg successfully became an internationally recognised site to investigate Parkinson’s disease.